Compare KWR & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KWR | BHC |
|---|---|---|
| Founded | 1918 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.0B |
| IPO Year | 1994 | 1996 |
| Metric | KWR | BHC |
|---|---|---|
| Price | $140.59 | $5.50 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 3 |
| Target Price | ★ $167.00 | $8.00 |
| AVG Volume (30 Days) | 128.7K | ★ 1.8M |
| Earning Date | 04-30-2026 | 04-29-2026 |
| Dividend Yield | ★ 1.52% | N/A |
| EPS Growth | N/A | ★ 423.08 |
| EPS | ★ 1.13 | N/A |
| Revenue | $1,888,634,000.00 | ★ $8,724,000,000.00 |
| Revenue This Year | $5.16 | $4.61 |
| Revenue Next Year | $3.63 | N/A |
| P/E Ratio | $123.21 | ★ N/A |
| Revenue Growth | ★ 2.66 | N/A |
| 52 Week Low | $103.36 | $4.41 |
| 52 Week High | $183.01 | $8.69 |
| Indicator | KWR | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 54.34 | 48.84 |
| Support Level | $128.51 | $5.48 |
| Resistance Level | $145.92 | $5.62 |
| Average True Range (ATR) | 5.23 | 0.20 |
| MACD | -0.48 | -0.01 |
| Stochastic Oscillator | 54.65 | 36.92 |
Quaker Houghton manufactures and sells a variety of industrial process fluids. The company's product portfolio includes metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids, and surface treatment chemicals. The company's geographic segments include the Americas, EMEA, and Asia/Pacific. The majority of the company's revenue is earned from the Americas.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.